UNSPSC 51422116: Fluocortin butyl ester

This classification denotes a dermatologic agent and glucocorticoid with the molecular formula C26H35FO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6N7OA9MO7O, chemically known as pregna-1,4-dien-21-oic acid, 6-fluoro-11-hydroxy-16-methyl-3,20-dioxo-, butyl ester (6.alpha.,11.beta.,16.alpha.)-, but more generally known as fluocortin butyl ester, which bears US NIH Compound Identifier 39034.

European Medicines Agency schedules fluocortin butyl ester or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07716MIG. Most nations, for tariff purposes, schedule fluocortin butyl ester under HS 29372200. SMILES: CCCCOC(=O)C(=O)[C@H]1[C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2C[C@@H](C4=CC(=O)C=C[C@]34C)F)O)C)C.

UNSPSC 51422116 Fluocortin butyl ester is a Commodity code that does not align with the recent state and local procurement activity posted under it. The single recent opportunity sourced under this code — Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 — solicits naloxone and safe drug deactivation systems, which fall outside the scope of fluocortin butyl ester, a corticosteroid pharmaceutical. The mismatch suggests either a coding error in the source data or a vendor-classification anomaly in the jurisdiction's procurement system.

No recent state and local opportunities substantively align with fluocortin butyl ester procurement activity. The code shows minimal recent activity in the dataset, and the single record tagged to it does not represent purchases of this commodity.